BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1435 related articles for article (PubMed ID: 19730258)

  • 1. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.
    Boerma EC; Koopmans M; Konijn A; Kaiferova K; Bakker AJ; van Roon EN; Buter H; Bruins N; Egbers PH; Gerritsen RT; Koetsier PM; Kingma WP; Kuiper MA; Ince C
    Crit Care Med; 2010 Jan; 38(1):93-100. PubMed ID: 19730258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot study.
    van der Voort PH; van Zanten M; Bosman RJ; van Stijn I; Wester JP; van Raalte R; Oudemans-van Straaten HM; Zandstra DF
    Eur J Anaesthesiol; 2015 Mar; 32(3):189-98. PubMed ID: 25032942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.
    Rice TW; Wheeler AP; Bernard GR; Vincent JL; Angus DC; Aikawa N; Demeyer I; Sainati S; Amlot N; Cao C; Ii M; Matsuda H; Mouri K; Cohen J
    Crit Care Med; 2010 Aug; 38(8):1685-94. PubMed ID: 20562702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome.
    De Backer D; Donadello K; Sakr Y; Ospina-Tascon G; Salgado D; Scolletta S; Vincent JL
    Crit Care Med; 2013 Mar; 41(3):791-9. PubMed ID: 23318492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.
    Bayer O; Reinhart K; Kohl M; Kabisch B; Marshall J; Sakr Y; Bauer M; Hartog C; Schwarzkopf D; Riedemann N
    Crit Care Med; 2012 Sep; 40(9):2543-51. PubMed ID: 22903091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
    Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertonic fluid administration in patients with septic shock: a prospective randomized controlled pilot study.
    van Haren FM; Sleigh J; Boerma EC; La Pine M; Bahr M; Pickkers P; van der Hoeven JG
    Shock; 2012 Mar; 37(3):268-75. PubMed ID: 22089205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival.
    Trzeciak S; Dellinger RP; Parrillo JE; Guglielmi M; Bajaj J; Abate NL; Arnold RC; Colilla S; Zanotti S; Hollenberg SM;
    Ann Emerg Med; 2007 Jan; 49(1):88-98, 98.e1-2. PubMed ID: 17095120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of inhaled nitric oxide for the treatment of microcirculatory dysfunction in patients with sepsis*.
    Trzeciak S; Glaspey LJ; Dellinger RP; Durflinger P; Anderson K; Dezfulian C; Roberts BW; Chansky ME; Parrillo JE; Hollenberg SM
    Crit Care Med; 2014 Dec; 42(12):2482-92. PubMed ID: 25080051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
    Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
    Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis.
    Boerma EC; van der Voort PH; Spronk PE; Ince C
    Crit Care Med; 2007 Apr; 35(4):1055-60. PubMed ID: 17334238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock.
    Edul VS; Enrico C; Laviolle B; Vazquez AR; Ince C; Dubin A
    Crit Care Med; 2012 May; 40(5):1443-8. PubMed ID: 22430243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.
    Mentzelopoulos SD; Zakynthinos SG; Tzoufi M; Katsios N; Papastylianou A; Gkisioti S; Stathopoulos A; Kollintza A; Stamataki E; Roussos C
    Arch Intern Med; 2009 Jan; 169(1):15-24. PubMed ID: 19139319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis.
    Tidswell M; Tillis W; Larosa SP; Lynn M; Wittek AE; Kao R; Wheeler J; Gogate J; Opal SM;
    Crit Care Med; 2010 Jan; 38(1):72-83. PubMed ID: 19661804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
    Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
    Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual microcirculatory effects of enalaprilat in an ovine model of septic shock.
    Salgado DR; He X; Su F; de Sousa DB; Penaccini L; Maciel LK; Taccone F; Rocco JR; Silva E; De Backer D; Vincent JL
    Shock; 2011 Jun; 35(6):542-9. PubMed ID: 21283060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masseter tissue oxygen saturation predicts normal central venous oxygen saturation during early goal-directed therapy and predicts mortality in patients with severe sepsis.
    Colin G; Nardi O; Polito A; Aboab J; Maxime V; Clair B; Friedman D; Orlikowski D; Sharshar T; Annane D
    Crit Care Med; 2012 Feb; 40(2):435-40. PubMed ID: 22020233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
    Jacobs S; Price Evans DA; Tariq M; Al Omar NF
    Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.